Department of Molecular Systems Biology, Faculty of Life Sciences, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.
Immunotherapy. 2013 Jan;5(1):9-12. doi: 10.2217/imt.12.146.
Within the expanding area of molecular pharming, the development of plants for manufacturing immunoglobulins, enzymes, virus-like particles and vaccines has become a major focus point. On 21 September 2012, the meeting 'Molecular Pharming - recent progress in manufacturing medicines in plants', hosted by EuroSciCon, was held at the Bioscience Catalyst campus, Stevenage, UK. The scientific program of this eventful meeting covered diverse highlights of biopharming: monoclonal antibodies, virus-like particles from transient and chloroplast expression systems, for example, for Dengue and HPV, apolipoproteins from safflower seeds, and new production platforms, such as potato or hydroponics by rhizosecretion. This report summarizes the stimulating scientific presentations and fruitful panel discussions on the current topics in this promising research field.
在分子制药不断扩展的领域中,利用植物生产免疫球蛋白、酶、病毒样颗粒和疫苗已成为一个主要焦点。2012 年 9 月 21 日,由 EuroSciCon 主办的“分子制药——在植物中制造药物的最新进展”会议在英国史蒂文纳吉的 Bioscience Catalyst 园区举行。本次会议的科学计划涵盖了生物制药的多个亮点:单克隆抗体、瞬时和叶绿体表达系统的病毒样颗粒,例如登革热和 HPV、红花种子中的载脂蛋白,以及新的生产平台,如通过根分泌的马铃薯或水培。本报告总结了在这一充满希望的研究领域的当前课题上,激动人心的科学演讲和富有成效的小组讨论。